Summary
Non-insulin-dependent diabetic (NIDDM) patients were studied during a modified euglycaemic state when fasting hyperglycaemia was normalized by a prior (−210 to −150 min) — and later withdrawn (−150–0 min) — intravenous insulin infusion. Glucose metabolism was assessed in NIDDM patients (n=10) and matched control subjects (n=10) using tritiated glucose turnover rates, indirect calorimetry and skeletal muscle glycogen synthase activity determinations. Total and non-oxidative exogenous glycolytic flux rates were measured using appearance rates of tritiated water. A+180 min euglycaemic hyperinsulinaemic (40 mU·m−2·min−1) clamp was performed to determine the insulin responsiveness of the various metabolic pathways. Plasma glucose concentration increased spontaneously during baseline measurements in the NIDDM patients (−120 to 0 min: 4.8±0.3 to 7.0±0.3 mmol/l; p<0.01), and was primarily due to an elevated rate of hepatic glucose production (3.16±0.13 vs 2.51±0.16 mg·kg FFM−1·min−1; p<0.01). In the NIDDM subjects baseline glucose oxidation was decreased (0.92±0.17 vs 1.33±0.14 mg·kg FFM−1·min−1; p<0.01) in the presence of a normal rate of total exogenous glycolytic flux and skeletal muscle glycogen synthase activity. The simultaneous finding of an increased lipid oxidation rate (1.95±0.13 vs 1.61±0.07 mg·kg FFM−1·min−1; p=0.05) and increased plasma lactate concentrations (0.86±0.05 vs 0.66±0.03 mmol/l; p=0.01) are consistent with a role for both the glucose-fatty acid cycle and the Cori cycle in the maintenance and development of fasting hyperglycaemia in NIDDM during decompensation. Insulin resistance was demonstrated during the hyperinsulinaemic clamp in the NIDDM patients with a decrease in the major peripheral pathways of intracellular glucose metabolism (oxidation, storage and muscle glycogen synthase activity), but not in the pathway of non-oxidative glycolytic flux which was not completely suppressed during insulin infusion in the NIDDM patients (0.55±0.15 mg·kg FFM−1·min−1; p<0.05 vs 0; control subjects: 0.17±0.29; NS vs 0). Thus, these data also indicate that the defect(s) of peripheral (skeletal muscle) glucose processing in NIDDM goes beyond the site of glucose transport across the cell membrane.
Article PDF
Similar content being viewed by others
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- FFM:
-
fat free mass
- HGP:
-
hepatic glucose production
- Rd :
-
peripheral glucose disposal (uptake) rate
- G6P:
-
glucose 6-phosphate
- UDPG:
-
uridine diphosphate glucose
- FV:
-
fractional velocity
References
Gerich JE (1991) Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 34:607–610
DeFronzo RA (1992) Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389–397
Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F (1994) Pathogenesis of type 2 diabetes mellitus (NIDDM): the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment. Diabetologia 37(2):217–221
Hother Nielsen O, Beck-Nielsen H (1990) On the determination of basal glucose production rate in patients with type 2 (non-insulin- dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33:603–610
Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H (1992) Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80–88
Halter JB, Graf RJ, Porte DJ (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48:946–954
Vaag A, Hother-Nielsen O, Skött P, Andersen P, Richter EA, Beck-Nielsen H (1992) Effect of acute hyperglycaemia on glucose metabolism in skeletal muscles in IDDM patients. Diabetes 41:174–182
Hother Nielsen O, Vaag A, Skott P, Beck Nielsen H (1993) Effect of hyperglycaemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism 42:86–93
Gray RS, Scarlett JA, Griffin J, Olefsky JM, Kolterman OG (1982) In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man. Diabetes 31:929–936
Rossetti L, Giaccari A (1990) Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycaemic clamp study in normal and diabetic rats. J Clin Invest 85:1785–1792
Christopher MJ, Rantzau C, Ward GM, Alford FP (1994) Impact of variable insulinaemia and glycemia on in vivo glycolysis and glucose storage in dogs. Am J Physiol (Endocrinol Metab) 266 (29):E62-E71
Del Prato S, Bonadonna RC, Bonora E, et al. (1993) Characterization of cellular defects of insulin action in Type 2 (non- insulin-dependent) diabetes mellitus. J Clin Invest 91(2):484–494
Rossetti L, Lee Y-T, Rutz J, Aldridge SC, Shamoon H, Boden G (1993) Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol (Endocrinol Metab) 265 (28):E761-E769
Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H (1991) Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:239–245
Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223–228
Vaag A, Henriksen JE, Beck Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782–788
Schalin Jantti C, Harkonen M, Groop LC (1992) Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598–604
Wells AM, Sutcliffe IC, Johnson AB, Taylor R (1993) Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes 42:583–589
Groop LC, Kankuri M, Schalin Jantti C, et al. (1993) Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328:10–14
McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M (1976) Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565–573
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM (1990) Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 258:E16-E23
Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634
Ferrannini E (1983) The theoretical basis of indirect calorimetry: a review. Metabolism 37:287–301
Tappy L, Owen OE, Boden G (1988) Effect of hyperinsulinaemia on urea pool size and substrate oxidation rates. Diabetes 37:1212–1216
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430
Cowan JS, Hetenyi GJ (1971) Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. Metabolism 20:360–372
Bell PM, Firth RG, Rizza RA (1986) Effects of hyperglycaemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose. Diabetes 35:642–648
Hostler KY, Landau BR (1967) Estimation of the pentose cycle contribution to glucose metabolism in tissue in vivo. Biochemestry 6:2961–2964
Karlander S, Roovete A, Vranic M, Efendic S (1986) Glucose and fructose 6-phosphate cycle in humans. Am J Physiol 251:E530-E536
Spence JT, Koudelka AP (1985) Pathway of glycogen synthesis from glucose in hepatocytes maintained in primary culture. J Biol Chem 260:1521–1526
Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810–817
Butler PC, Kryshak EJ, Marsh M, Rizza RA (1990) Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes 39:1373–1380
Mandarino LJ, Wright KS, Verity LS, et al. (1987) Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest 80:655–663
Thomas JA, Schlender KK, Larner J (1968) A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25:486–499
Itaya K, Ui M (1965) Colorimetric determination of free fatty acids in biological fluids. J Lipid Res 6:16–20
Passonneau JV (1974) L-(+)-lactate. Flouroetric method. In: Bergmeyer HV (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1468–1472
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789
Vaag A, Handberg A, Skött P, Richter EA, Beck-Nielsen H (1994) Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol 130:70–79
Cori CF (1931) Mammalian carbohydrate metabolism. Physiol Rev 11:143–275
Zawadzki JK, Wolfe RR, Mott DM, Lillioja S, Howard BV, Bogardus C (1988) Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes 37:154–159
Consoli A, Nurjhan N, Reilly JJJ, Bier DM, Gerich JE (1990) Mechanism of increased gluconeogenesis in non-insulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 86:2038–2045
Vranic M (1992) Banting Lecture: glucose turnover. A key to understanding the pathogenesis of diabetes (indirect effects of insulin). Diabetes 41:1188–1206
Argyraki M, Wright PD, Venables CW, Proud G, Taylor R (1989) In vitro study of human skeletal muscle strips: effect of nonesterified fatty acid supply on glucose storage. Metabolism 38:1183–1187
Boden G, Jadali F, White J, et al. (1991) Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960–966
Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H (1991) Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 88:1282–1290
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaag, A., Alford, F., Henriksen, F.L. et al. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38, 326–336 (1995). https://doi.org/10.1007/BF00400638
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400638